GOLDSMITH MARK A sold RVMD
March 2, 2026 · Form 4 insider transaction
GOLDSMITH MARK A sold 400 shares of Revolution Medicines, Inc. at $100.12 per share, a transaction worth $40.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$100.12
Total value
$40.0K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after66,924
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was executed in multiple trades at prices ranging from $99.79 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Held by Jonathan Goldsmith Revocable Trust.